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ABSTRACT
Background: Asthma is a chronic lung disease that inflames and narrows the airways.
This results in recurrent episodes of coughing, wheezing, shortness of breath, and chest
tightness. Although the causes of asthma are poorly understood, genetic and
environmental factors have been implicated in the development and exacerbation of the
disease. Among environmental risk factors, cigarette smoke is a well-known risk factor to
trigger asthma symptoms. Exposure to secondhand smoke irritates the airways and may
trigger an attack in adults with asthma. Smoke-free laws and regulations in the United
States differ by state. The enforcement of smoke-free legislation has been related to
asthma rates as it has been shown that they lead to a sustained drop in emergency hospital
admission for asthma among adults. These laws and regulations are also necessary in
reducing smoking rate and secondhand smoke exposure.
Objective: The purpose of this thesis is to examine the association between tobacco
smoke rates and asthma status among adults at the national and state levels and to
evaluate the effects of state smoke-free laws and regulations on tobacco smoking rate
among adults with asthma.
Methods: The Centers for Disease Control and Prevention’s 2009–2010 Behavioral Risk
Factor Surveillance System data was used for the analyses. SAS-callable SUDAAN
(version 10.0.0, RTI International, NC) was utilized to account for the complex sampling
design of the BRFSS, and sample weights were used to produce estimates that were
generalizable to the state and U.S. adult population. In addition to calculating descriptive
statistics, chi-square tests and multivariate logistic regression were used to test for group
differences and association between variables of interest. State level smoking rates were
ranked to identify states that are in the lower and upper 20th percentiles and compare
them with states’ smoke-free laws and regulation status.
Results were considered significantly different if 95% confidence intervals (CIs) did not
overlap or if statistical testing at p<0.05 was applicable.
Results: Asthma prevalence rates are higher among adults that smoke cigarettes (10.5%,
[aPR] =1.2) compared to non-smokers (7.8%, [aPR] =1.0). Of the 869,519 adult
respondents in the survey, 8.5% reported having asthma. Nearly one-fifth (17.2%) of
adults without asthma smoked cigarettes, while (21.7 %) of adults with asthma smoked.
Females (10.5%) had higher asthma prevalence rates than males (6.4%). Black persons
(10.0%), persons of American Indian (13.0%) descent had higher, and those of Hispanic
(6.7%) descent had lower asthma rates than white persons (8.6%). Adults with a high
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school education or less (9.1%) had higher asthma rates than those with an education
level that was equivalent to a 4 year college or more (7.3%) , and those with low income
(<$15,000) had higher rates (13.3%) than those with high income (6.8%). Percentage of
male (23.4%) and females (20.7%) with asthma who smoke are higher than those that do
not smoke (19.3% and 15.1%, respectively).
Asthma prevalence rates and smoking rates vary by geographic location. Smoking rates
among adults with asthma was highest in the South (LA, AL, SC, TN, OK, MS, AR, WV,
KY) and a couple of Midwest states (OH, IN,). Evaluating the association between the
2008 State of Tobacco Control Report and smoking rate among adults with asthma by
state showed a statistically significant relationship between smoking rate among adults
with asthma and smoke-free policy and regulation at the state and national level. On
average, states with the lowest smoking rate among persons with asthma (smoking rates
less than 20th percentile) had significantly higher smoke-free policy grades (mean grade
[sd]=7.2 [1.99]) than states with a high smoking rate (smoking rate of 80th percentile or
more) (mean grade [sd]=2.0 [2.00]) (p-value < 0.00001).
Conclusion: Although most U.S. state smoke-free policies and regulations are relatively
new, it is evident that these laws are effective in promoting cessation among adults and
reducing nonsmokers’ exposure to secondhand smoke. The study found that smoke-free
laws may improve health by lowering asthma prevalence and smoking rates among adult
smokers. Also, these policies in turn protect non-smokers from the harmful health effects
of secondhand smoke.

Key Words: asthma, asthma prevalence, cigarette smoke, adults, smoke free policy
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CHAPTER I
INTRODUCTION
1.1 Background
Asthma is a respiratory disease that attacks the airways in the lungs; this chronic
inflammatory condition affects more than 25 million Americans (Centers for Disease, 2011).
Trends in current asthma prevalence rates have been on the rise with an estimated 16.5%
increase from 7.3% in 2001 to 8.5% in 2010 (Centers for Disease, 2011). The previous Centers
for Disease Control and Prevention (CDC) reports indicate significant differences in asthma
prevalence between many population subgroups. While differences exist between the
demographic subgroups- children, adults, males, females, whites, blacks, and Hispanics- there
has been a rising trend in asthma prevalence across all subgroups over the past few decades. For
instance, analyses of trends for 2001-2010 for current asthma prevalence for population-based
rates show that in 2010, females had higher prevalence than men (9.7% compared with 5.7%);
this prevalence rate has been increasing at a rate of 1.8% per year among males and females
(Centers for Disease, 2011). The rise in the asthma prevalence rates creates a substantial health
and economic burden on individuals and society (Hahn, 2010). It is estimated that the mean
annual per capita healthcare expenditure for asthma related cases in 2006 was $5,322 (in 2010
US dollars) (Rank, 2012); total cost estimate of asthma to the United States was $56 billion in
2007 (Barnett, 2011).
Science has not found a cure for asthma. The causes of asthma are poorly understood as
multiple factors (genetic predisposition, environment, gene-environment interactions) play a role
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in the development and worsening of asthma symptoms (Grassi, 2006;Ober, 2005;Willemsen,
2008;Yang, 2007). However, the rise in asthma in recent years cannot be attributed to changes
in genetic factors. Instead, intervention efforts to halt the increasing asthma prevalence should
be redirected to focus on environmental factors.
Cigarette smoking and secondhand smoke are among the main environmental triggers of
asthma. Even though it is known that smoking aggravates asthma symptoms, a higher
percentage of adults with asthma smoke when compared to the percentage of adults without
asthma that smoke (Table 3). The combination of asthma and active cigarette smoking results in
more pronounced asthma symptoms, accelerated decline in lung function, and reduce the body’s
response to corticosteroid treatment (asthma medication) (Levy, 2002).
Smoke-free laws effectively reduce smoking and secondhand smoke exposure. In addition,
smoke free legislation is shown to improve indoor air quality, increase the likelihood of smoke
cessation and lower the rates of asthma exacerbations (Hahn, 2010;Jill S. Rumberger,
2010;Levy, 2002). It has been noted that aside from the health outcomes, smoke free legislation
does not negatively affect employment or business profits (Haw, 2007;Prevention, 2007).
Smoke free legislation is an important step that needs to be taken into account by public officials
as a public health intervention strategy that reduces the long-term health and financial burden of
cigarette/tobacco use. Asthma is a long-term disease that cannot be cured but through policy
changes it can be relatively controlled and managed in order for individuals to live normal, active
lifestyles (Centers for Disease, 2011).
1.2 Purpose of Study
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The purpose of this study is to investigate the relationship between the prevalence of smoking
and secondhand smoking exposure among adults with asthma by analyzing data from the 20092010 Behavioral Risk Factor Surveillance System. In addition, the impact of smoke-free policies
on smoking prevalence among adults with asthma was examined by studying The American
Lung Association State of Tobacco Control 2008 report that tracks progress on key tobacco
control policies at the state and federal level and assigns grades to tobacco control laws and
regulation enacted as of January 1, 2009 (Association, 2012). The results of this study bring light
to whether smoke-free policies are cost effective in terms of reducing the annual direct
healthcare cost of asthma and the indirect cost measured by lost work days (Association, 2012).
1.3 Research Questions
The purpose of this study is to gather data from the Behavioral Risk Factor Surveillance
System (BRFSS) and the American Lung Association State of Tobacco Control report in
order to answer the following questions:
I.
II.

What is the current asthma prevalence rate and factors associated with it?
What is the percentage of smokers by asthma status, selected demographic characteristics
and state?

III.

What is the impact of state wide smoke-free laws on smoking rates among persons with
asthma?
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CHAPTER II
REVIEW OF THE LITERATURE
2.1 State of Asthma Defined
Asthma continues to be a major public health concern in the United States and worldwide.
Asthma is a chronic and life-threatening disease that affects 25 million people in the U.S. and
235 million people around the world, according to the World Health Organization, 2012(To,
2012). In the U.S. asthma affects nearly 8% of the adult population and 9.5% of children aged 017 years. Projections speculate that by year 2025, the number of people worldwide with asthma
will increase to 400 million, a 70% surge, as countries become more urbanize (To, 2012). The
increase in prevalence poses a substantial concern in terms of the health and financial burden that
the disease has on the general population and the country. In order to tackle the complexities of
asthma, additional research is needed to understand the causes of asthma.
In asthma patients the airways in the lungs become inflamed which makes the airways
sensitive; certain irritants cause the airways to tighten, become smaller and produce extra mucus;
when the airways become obstructed the air flow to the lungs decreases making it harder to
breath (Piipari, 2004). Asthma presents itself with the following respiratory symptoms:
wheezing, coughing, nocturnal chest tightness, shortness of breath or attacks of breathlessness
following activity, and chest tightness particularly at night or early in the morning (Cerveri,
2012). The airway obstruction that characterizes asthma is reversible and patients with this
disease respond to corticosteroid therapy whether inhaled or orally (Cerveri, 2012).
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At present, there is no known cure for asthma but people with asthma can be symptom free
for days, even years with an affective asthma management and control (National Asthma, 2007
#111). The National Asthma Education and Prevention Program (NAEPP) was established in
1989 to address the asthma-related prevalence and mortality rates and to enhance the lives of
persons with asthma. NAEPP convenes a panel of expert to perform a systematic review of all
published scientific literature and report new finding or confirm that current asthma guidelines
reflect scientific advances. This panel of 18 experts is independently appointed by the NAEPP
and prepares a report, Expert Panel Report 3-Guidelines for the Diagnosis and Management of
Asthma (EPR-3), that examines the up-to-date scientific progress made in the field of asthma
control and management (National Asthma, 2007). Based on EPR-3, an affective asthma
management consists of four components:
1. Assessment of asthma severity and control, there are two domains (National Asthma,
2007):
a. Assessment of impairments
With regards to assessing asthma severity, physicians are required to examine the
symptoms and lung function of current impairment. In evaluating asthma impairment, the
following symptoms are taken into consideration: daytime symptom, awakening at night, the
need for inhaled Short-Acting Beta2-Agonists (SABA) for quick relief of symptoms, missing
work or school days, the inability to engage in normal day-to-day activity and a quality-of-life
assessment (National Asthma, 2007).
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In terms of lung function, a spirometer classifies severity by measuring the forced
expiratory volume in 1 second (FEV1), the forced expiratory volume in six seconds (FEV6) in
adults, and the forced vital capacity (FVC) (Fuhlbrigge, 2001). The use of this tool has been
found effective in cross-sectional and longitudinal studies of children that provided proof of an
association between severity of airflow obstruction and the risk of exacerbations (Fuhlbrigge,
2001). These studies report FEV1 to be useful in indicating risk for exacerbations; while
FEV1/FVC is a more accurate measure of severity in the impairment domain (National Asthma,
2007).
Aside from examining the effects of asthma on the quality of life and current functional
capacity on an ongoing basis, we also need to assess the risks asthma presents for adverse events
in the future.
b. Assessment of risk for future exacerbation (National Asthma, 2007)
The second part of assessing asthma severity and controlling it is to measure the future risks
that asthma may present. These adverse events include exacerbations of asthma presented by
episodes of progressively deteriorating shortness of breath, wheezing, chest tightness, and coughand the risk of death.
Patients found to be at a high risk of future exacerbations are closely monitored and will need
to undergo periodic assessments by their physicians. Depending on the frequency and intensity
of exacerbations (measured by hospitalization, ICU admission, or unscheduled clinical care),
several interventions are to be considered (discussed in the following three asthma management
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components). To reduce risk, clinicians focus on avoiding frequently occurring exacerbations of
asthma and reducing the need for ED visits or hospitalizations (National Asthma, 2007). Also,
they work to stop the progressive loss of lung function especially in children. Finally, they
present patients with options of prescriptive medicine with minimal or no side effects.
2. Education for people with asthma and those that provide asthma care (National
Asthma, 2007)
EPR-3 provides recommendation on asthma self-management education at multiple points of
care, tools for asthma self-management, and provider education. It is believed that specialized
training in self-management is essential in creating behavior that modifies the outcomes of
chronic illnesses such as asthma. Educating persons with asthma in self-management skills of
‘self-assessment, use of medications, and actions to prevent or control exacerbations’ will result
in ‘reduction in urgent care visits and hospitalizations, reduction of asthma-related care costs,
and improvement in health status’ (National Asthma, 2007, p.96)
3. Control of environmental factors and co-morbid conditions that affect asthma (National
Asthma, 2007)
Evidence has shown a strong association, in people who have asthma, between exposure to
allergens and an increase in asthma symptoms and exacerbation of the disease (EPR-3).

EPR-3

notes that reducing exposure to indoor and outdoor inhalant allergens to which the patient is
sensitized can improve asthma control. The report recommends an action plan for effective
indoor and outdoor allergen avoidance in a multifaceted approach.
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4. Appropriate medical treatment (National Asthma, 2007)
Among medical treatment there are two types of asthma medications: quick relief
medications provide prompt relief of symptoms and long-term control medications prevents
symptoms by reducing inflammation. Quick-relief meds are to be taken as needed when asthma
symptom exacerbations occur, they do not provide long-term asthma control. On the other hand,
to control asthma symptoms long-term patients need to take long-term control medication daily
regardless of experience in symptoms. Corticosteroids are the first and most common choice of
long-term controller medications (National Asthma, 2007).
Corticosteroids is an anti-inflammatory treatment that suppresses the inflamed airways ‘by
inducing the recruitment of the nuclear enzyme histone deacetylase 2 (HDAC2) to multiple
activated inflammatory genes, which leads to deacetylation of the hyperacetylated genes, thereby
suppressing inflammation’ (Barnes, 2008, p.7). Several studies confirm that the regular
administration of corticosteroids have been found to reverse the airway obstruction and
inflammation caused by the disease (Fuhlbrigge, 2001;Piipari, 2004).

2.2 Risk Factors
Asthma is a condition that is complex with genetic as well environmental components.
Researchers believe that exposure to a number of factors (genetic, environmental) and
interactions between these factors are association with the exacerbation of asthma-like symptoms
and the development of the disease (Grassi, 2006;Ober, 2005;Willemsen, 2008;Yang, 2007).
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Other host-related factors have also been found to be associated with the occurrence of
asthma in adults and children. Elements that are considered host-related include the age of the
patient, their sex, race, ethnicity, smoking status, and obesity. Co-morbid conditions such as
gastro-esophageal reflux disease [GERD] and chronic sinus disease have been shown to have a
link to asthma (Pearlman, 2009). These host-related factors are classified as modifiable
(education, income, health insurance status, smoking, obesity, and co-morbid conditions) (Beane,
2007;Gwynn, 2004;Services, 2006;Strine, 2004) and non-modifiable (e.g., heredity, age, sex,
race, and ethnicity) (Gwynn, 2004;Strine, 2004;Willemsen, 2008).
Previous studies show that differences in life experiences (e.g. family, social, and economic
environment), lifestyle choices (smoking, obesity, leisure time physical activities), and exposure
to adverse indoor and outdoor environment factors (e.g., mold, pollens, house dust mites,
cockroaches, rodents, animal allergens, environmental tobacco smoking [ETS], and other air
pollutants) may account for some of the racial and ethnic differences in asthma prevalence
(Committee on the Assessment of Asthma and Indoor Air, 2000;Gwynn, 2004;Strine, 2004).
Even though previous studies have identified potential predictors of asthma, specific information
about the predictive factors among racial and ethnic groups has been limited. These study
findings were limited to either a few major race/ethnic groups (e.g., white vs. non-white or
whites vs. blacks, Hispanics, and other race) or predictive factors were examined by controlling
for the effects of race/ethnicity.
The potential determinants of asthma vary on a broad spectrum that ranges from genetic
history to environmental factors.
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Genetic
While genetic predisposition may result in the development of allergies (eczema or hay
fever) and asthma, the genotype of asthma is multifactorial and positive family history does not
necessarily predict the presence of the disease (Pope, 2002). Gene studies have found the
presence of age-specific genetic effects (Dijk, 2013;Forno, 2012;Henderson, 2009). Several
published studies and meta-analysis show genome-wide association for childhood and adult
asthma, obtaining genetic associations at a genome-wide significant level, either in the original
cohort, the replication cohort, or in a combined analysis. It is estimated that at least 40 genes
were found to be associated with the development of asthma; replication studies in independent
populations confirm these findings (Forno, 2012).
In the US, a study on an original population of Non-Hispanic whites found that the presence
of the gene, PDE4D, had a strong association with the development of asthma in children and
adults (Himes, 2009). The PDE4D sequence works to constrict the airways smooth-muscle cells,
leading to asthma. The same study was replicated using African-Americans, European
Americans, US Hispanics, and British and resulted in the same finding. However, the presence of
PDE4D in the African-American population had no association with the development of asthma
in adults or children (Forno, 2012;Himes, 2009).
Other findings in gene variants are essential in understanding the role of genetics in asthma
pathophysiology and the effectiveness of certain gene inhibitor medications. Henderson et al.
confirms that in order to find solutions to questions about the cause of asthma, we have to
maximize our knowledge on genome-wide linkage to asthma (Dijk, 2013). To increase our
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understanding of the etiology and natural history of asthma, ‘it is important to consider the
impact of precise classification of phenotypes on issues such as replication of associations,
misclassification bias and harmonization of outcomes across populations large enough to achieve
sufficient statistical power, particularly for the detection of gene-gene and gene-environment
interactions’ (Henderson, 2009).
Demographic
Predictors of asthma differ by sex, race/ethnicity, age, education, income, and smoking
status. Asthma disproportionately affects certain demographic groups, and the disproportionate
impact has persisted over time (Frieden, 2011;Prevention, 2007;Centers for Disease, 2011).
Current asthma prevalence is higher among women than men and among children (9.5%)
than adults (7.7%) (Subbarao, 2009). In women, asthma prevalence is 9.2% compared to 7.0%
for men. Subbarao et al., summarizes the findings of several research papers by reporting that in
women airway hyper responsiveness increases in female in adulthood compared to men making
them more susceptible to developing asthma. At puberty the incidence and prevalence of asthma
starts to switch from being higher in boys to becoming higher in girls (Subbarao, 2009). Studies
have been unable to find any scientific evidence that pubertal development is a resultant of
asthma occurrence. This shift in the occurrence of asthma appears between the sexes during the
first and second decades of life and during the fifth or sixth decades (Subbarao, 2009). In other
words, before the age of 10 or mid-teen years, boys have higher frequency of asthma than girls.
While no scientific evidence shows interference between puberty and asthma occurrence, after
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puberty girls asthma rates starts to rise surpassing the rates of boys. However, investigations
found that in general occurrence of asthma decreases with age in both sexes.
Aside from the gender differences in asthma prevalence, other selected characteristics
affect the rates of asthma. For instance, asthma prevalence differs by race, ethnicity, poverty
status, geographic region and urbanicity. Trends in population-based asthma prevalence by race
and ethnicity show the interaction between prevalence rates and how they relate to these two
factors. In the United States, the average annual 2008-2010 asthma prevalence was higher
among blacks (11.1%), American Indian or Alaska Native (AI/AN) (8.8%) , persons of multiple
race, and lower among Asian (5.3%) and Hispanics (6.3%) than whites (7.3%) (Gwynn,
2004;National Asthma, 2007;Prevention, 1999;Prevention, 2000;Smith, 2005;Strine, 2004).
Compared with non-Hispanic white and non-Hispanic black persons, current asthma prevalence
is higher among Puerto Rican and lower among Mexican persons.
The National Health Interview Survey (NHIS) shows that family income along with
geographic region and urbanicity play an important role on asthma prevalence. Those with
family income below the federal poverty threshold (11.2%) have higher current asthma
prevalence rates compared to persons with family income at or above the federal poverty line
(8.5%) (Akinbami, 2012). Combining this finding with the examination of geographic region,
analysts found that prevalence is higher in the Northeast (8.8%) than in the West (8.0%) and
South (7.6%) and in the Midwest (8.7%) compared to the South (7.6%) (Akinbami, 2012).
However, when prevalence rates for urbanicity were examined, current asthma prevalence did
not differ between metropolitan and nonmetropolitan areas.
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Environmental
Among the factors that affect the current asthma status are seasonal and non-seasonal
allergens such as cockroaches, dust mites, mold, pets and animals, pollen, and other air
pollutants and asthma irritants such as cigarette smoke (Huss, 2001). The National Institutes of
Health (NIH) and the Environmental Protection Agency (EPA) funded a 2-year study that found
a strong relationship between modestly increasing the levels of air pollution and elevated
frequency of asthma symptoms and lower lung function (Pope, 2002). These environmental
factors affect a person’s life differently and an individual’s reaction to them may change over
time.
Indoor air pollution: (smoke, mold, cigarette, noxious fumes, cleaning products, paints) have
been found to help in the development of allergic reactions and asthma, especially in children.
Exposure to certain air pollutants such as O3, PM10, CO, SO2 and NO2 have been linked to an
increase in asthma symptoms (Agrawal, 2012;Huss, 2001;Mishra, 2002). Studies have found
that a main source of indoor pollution is cooking smoke, which is the product of biomass and
solid fuel combustion used in developing countries. Exposure to cooking smoke and tobacco
smoke indoors increases the severity of asthma attacks, reduces the efficacy of treatments, and
worsens the decline of lung functions (Agrawal, 2012;Huss, 2001;Mishra, 2002).
The most commonly research topics that are thought to be related to the onset of asthma are
exposure to house dust mites, cockroach and pet-derived allergens. Exposure to mite and
cockroach allergens early in life and in homes causes children to become increasingly sensitized.
A study that examined the found that 88% of patients that were exposed furred or feathered pets
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in the house tested positive for allergy skin tests which have been associated with asthma
morbidity (Huss, 2001). In the United States, the strongest risk factors associated with the
development of asthma are sensitization to dog and cat allergens (Huss, 2001). Studies have
found that avoidance of allergens early in life helps prevent sensitization.
Outdoor air pollution: the two commonly described air pollutants that can affect health and
are monitored by the U.S. Environmental Protection Agency (EPA) are particulate matter and
ozone (Girardot, 2006;McConnell, 2002). Particulate matter are solid or liquid particles
suspended in the air and can be man-made (e.g., smoke, fumes, soot, and combustion by
products) or natural (e.g., windblown dust, volcanoes, agricultural crops, forest fires, pollen, and
sea salt) (Brook, 2010;Dockery, 2009;Pope, 2006). The relationship between exposure to
concentrated outdoor particulate matter and adverse health effects includes lung cancer,
premature death, exacerbation of respiratory and cardiovascular disease (e.g., asthma and
COPD), and increased risks for cardiovascular morbidity (e.g., myocardial infarction and
arrhythmia) (Brook, 2010;Dockery, 2009;Pope, 2006).
Ozone, the second well-characterized air pollutant, is the most abundant photochemical
oxidant (Hoppe, 2003). This atmospheric pollutant when inhaled exacerbates asthma and lessens
the ability of the lungs to eliminate infectious agents and toxins (Girardot, 2006;McConnell,
2002). At ground level, ozone appears as urban smog and affects people with outdoor
occupations, athletes and sensitive groups (children, elderly, asthmatics or people with other
respiratory or cardiovascular disease) (Girardot, 2006;Hoppe, 2003;Triche, 2006).
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Research on the topic of asthma development provides no consensus on whether
environmental factors directly result in the development of asthma or only trigger asthma
symptoms (Beane, 2007;Institute of Medicine, 2000;Frieden, 2011). Different approaches to
prevent and treat asthma continue to be studied.

2.3 Smoking and Asthma
Tobacco smoke is one of well-known risk factors for asthma. Persons with asthma are more
sensitive to the toxic chemicals and irritants that are brought about by cigarette smoke. Piipari el
al reported that the risk of developing asthma was significantly higher among current smokers
and among former smokers compared with those who have never smoked (OR, 1.33 and 1.49
respectively) (Piipari, 2004). Sufficient evidence supports that exposure to secondhand tobacco
smoke, also known as environmental tobacco smoke (ETS) causes exacerbation of asthma
symptoms among preschool age children (Institute of Medicine, 2000).
Similar to asthma the common symptoms of smoking are wheezing, coughing, shortness of
breath, nasal congestion, and burning or watery eyes. Among the environmental factor of
asthma, cigarette smoking and secondhand smoke are important triggers (Cerveri,
2012;Stapleton, 2011;Piipari, 2004). Tobacco smoke increases inflammation and mucus
secretion in the airways which leads to worsening asthma symptoms, more airway inflammation,
and reduces response to inhaled corticosteroid treatment, and an accelerated decline in lung
function (Institute of Medicine, 2000;Piipari, 2004). It is well documented that exposure to
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tobacco smoke or prolonged periods in asthmatic patients contributes to a decline (estimated
18%) in lung function (Institute of Medicine, 2000;Piipari, 2004).
Furthermore, studies have found that patients with asthma that smoke or are exposed to
second hand smoke respond poorly to corticosteroid treatments. In cases where patients had
severe asthma, increasing the dosage of inhaled or oral corticosteroids failed to suppress
inflammation (Barnes, 2008). This is the result of corticosteroid resistance that is believed to be
linked to impaired nuclear enzyme histone deacetylase 2 (HDAC2) functions (Barnes, 2008). As
noted, the prevalence of smoking among adults has introduced additional complications to a
chronic disease that continues to affect the lives of a growing population.
Tobacco smoke contains more than 4,000 toxic substances (Spira, 2004). Irritating
substances settle in the moist lining of the airways (tar, carbon monoxide, nicotine, and more)
causing inflammation and increasing mucus secretion (Spira, 2004). Very few studies have been
done in humans to establish the effects of smoking on epithelial cells of the pulmonary airways
(Spira, 2004). Spira et al. has found that cigarette smoking decreased the functionality of several
tumor suppressor genes and genes that regulate airway inflammation. Another adverse outcome
of smoking is that it damages cilia in the airways. Cilia are microscopic hair-like projections
lining the epithelial cells that sweep dust and mucus out of the airways keeping them free from
infection; a process called mucociliary clearance (Leopold, 2009). The harmful toxins present in
tobacco smoke paralyzes the cilia cells allowing dust and mucus to accumulate in the airways, as
a result, more mucus can build up in the airways, triggering an asthma attack (Krieger,
2001;Leopold, 2009) Leopold et al. has shown that smoking not only inhibits the movement of
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cilia cells, but is also associated with the average shortening of airway epithelial cilia (by 13%)
which further reduces efficacy (Krieger, 2001). Long-term smoking will result in the
progressive destruction of cilia and thus a decrease in mucociliary clearance making smokers
more vulnerable for developing smoking-induced lung disease. However, depending on prior
smoking habits, the lungs have the ability to heal and smoking cessation allows the cilia to regrow and resume functioning within 2 years. Studies that examined effects of smoking cessation
have found that genes serving metabolizing and antioxidant functions reverted to normal levels
within 2 years, while tumor suppressor genes failed to return to never smoker levels after
quitting. Leopold et al. concludes that this finding may provide the rationale for ‘the continued
risk for developing lung cancer many years after individuals have ceased to smoke’ (Leopold,
2009).

2.4 Smoke free Legislation- health and economic outcomes
Effective smoke-free legislation is among the most fundamental public health intervention
measures that could reverse the adverse health effects of smoking. Research has shown that
when a comprehensive smoke free law is effectively implemented, the entire population gains in
terms of health benefits. Studies conducted in a number of countries (Canada, Italy, Ireland)
have shown a significant reduction in the levels of people reporting exposure to second hand
smoke. Also found as a result of smoke free legislation was a decline in respiratory/sensory
symptoms, emergency department visits for asthma among children and adults (18% for
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children, 24% for adults). Interestingly, in Ireland, emerging research has found that 1 year after
implement a smoking ban in the workplace, the risk for preterm birth declined by 25% and the
rate of maternal smoking decrease by 12% (Kabir, 2009).
Aside from the positive health outcomes of smoke-free legislation, the American Lung
Association release a study conducted by researchers at Penn State University that analyzed the
nationwide cost-benefit of smoking cessation treatments. The researchers found that smoking
costs the nation a combined annual $301 billion in lost productivity ($67.5 billion), premature
death ($117 billion), and health care expenditure ($116 billion) (Jill S. Rumberger, 2010). The
researchers concluded that depending on the smoking cessation counseling method, the return on
investment for the state could be up to 87% (Jill S. Rumberger, 2010).
Several strategies have been implemented and studied in an effort to reduce smoking
prevalence. The most common intervention is a comprehensive smoke free-state wide program,
banning smoking in public places, increasing the tax on cigarette sales. In Washington State,
Dilley et al. examined the health effects associated with tobacco control interventions (program,
policy, and price intervention for tobacco) to quantify the return on investment (Dilley, 2012).
This study was the first of its kind to investigate the association between multiple specific health
conditions (Ischemic heart disease hospitalizations, cerebrovascular disease hospitalizations,
chronic respiratory disease hospitalizations, esophageal cancer incidence, larynx cancer
incidence, oral cancer incidence, and lung cancer incidence) and multiple proven tobacco control
interventions (comprehensive state program, state policy banning smoking in public places and
price increases) (Dilley, 2012). The findings of the study concluded that the tobacco control
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interventions worked to lower hospitalization rates and would save the state of Washington an
estimated $1.5 billion in hospitalization.
Smoke-free legislation
National Health Service (NHS) statistics analyzed by researchers in Scotland found that the
introduction of smoke-free legislation resulted in a reduction to exposure to secondhand smoke
among nonsmokers living in nonsmoking household (Haw, 2007). Haw et al. measured the
amount of cotinine, an alkaloid found in tobacco, concentrations by collecting saliva samples
from smokers and nonsmokers. Then, the researchers compared the cotinine measurements in
the respondents prior to the smoke-free legislation and a year following it (Haw, 2007). The
overall geometric mean cotinine for nonsmokers living in nonsmoking households fell by 49%
(P-value less than 0.001). This significant reduction in exposure to secondhand smoke observed
in Scotland, leads the researchers to believe that smoke-free legislations may produce immediate
health gains as well as a reduce morbidity and mortality related to second-hand smoke(Haw,
2007). What the study adds to research in the topic of smoke-free legislation effects on the
population is that the main beneficiaries of the legislation are non-smokers living in nonsmoking homes as exposure to secondhand smoke was reduced in all public places and
workplaces but not in homes and private cars.
Cigarette tax
In the ongoing debate to lower smoking prevalence, cigarette tax is the most commonly
advocated means to reduce smoking. Legislative interventions to increase the price of cigarettes
have been found to discourage young adults from starting smoking as well as reducing the
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average cigarette consumption among current smokers (Services, 2005;CDC, 2000;Medicine,
2007) In 2009, the United States placed a 15% federal tax increase on the average pack of
cigarette price with a proposed additional average increase of 34%. Researchers at the
University of Illinois at Chicago measured the immediate impact of excise tax increase on youth
through May 2009 by using the Monitoring the Future survey, a national representative survey of
8th, 10th, and 12th grade students (Huang, 2012). Huang et al. found that the 62 cent-a-pack
increase resulted in an estimated average drop of 11.5%.
Martire et al. performed a study in Australia that compares the possible impacts of proposed
price increases on smoking prevalence in both the United States (U.S.) and Australia. The
researchers examine the effects of the proposed tax increases (U.S. - 34%, Australia- 49%) as
well as the probable effect of financial stress (Martire, 2011). The findings of the paper suggest
that the increase in tobacco tax will potentially lower the prevalence in both countries.
Implementation of tax increases was found to decrease smoking in lower socioeconomic status
groups by 2% in the U.S. and 8% in Australia. However, by taking into account the effects of
financial stress, Martire et al. found that smoking prevalence was reduced by 0.13% in the U.S.
and 0.36% in Australia (Martire, 2011). Therefore, the researchers believe that instead of
tacking this issue from one standpoint of taxing cigarettes, instead ‘policy makers need to
interrupt the negatively reinforcing cycle of smoking and financial stress’ by ‘providing free or
subsidized smoking cessation resources to reduce the economic burdens borne by financially
stressed smokers and facilitate quitting.’ (Martire, 2011, p.628)
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CHAPTER III
METHODOLOGY
3.1 Data Source
The Centers for Disease Control and Prevention’s 2009–2010 Behavioral Risk Factor
Surveillance System (BRFSS) data was used for the analyses. SAS-callable SUDAAN (version
10.0.0, RTI International, NC) was utilized to account for the complex sampling design of the
BRFSS and sample weights were used to produce estimates that were generalizable to the state
and U.S. adult population.
BRFSS is a joint partnership project with the Centers of Disease Control and Prevention
(CDC) and U.S. states and territories (William J. Curry, 2010). BRFSS is an ongoing statebased, random-digit dialed telephone survey of the non-institutionalized U.S. population, aged
18 years of older. The main purpose of the BRFSS is to gather uniform and state-specific data
on preventive health practices and risk behaviors that are linked to chronic diseases, injuries, and
preventable infectious diseases in the adult population. The data collection process of the
BRFSS is administered by state health departments with guidelines provided by CDC. The 2009
and 2010 BRFSS was conducted in the 50 states, the District of Columbia (DC), Puerto Rico
(PR), the U.S. Virgin Islands, Guam, American Samoa, and Palau (CDC, 2011). However, we
limited our analysis to 50 states and, the District of Columbia (DC). This survey is the world’s
largest ongoing survey with over half a million interviews conducted annually.
In order to have a representative sample of the population, BRFSS uses a statistical method
called post stratification (CDC, 2011). In post stratification, after data has been collected, data
is compare it to an auxiliary data set representation of the population to make sure that the
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distributions of demographic characteristics (age, race and ethnicity, sex, geographic region
within a population.) are within a few percentage points (Gelman, 2000). If the collected data
differ by more than the accepted range of percentage points, the sample data is adjust to conform
to the population’s parameters.
BRFSS measures personal behaviors that put an individual’s health at risk. To determine
current cigarette smoking, respondents are asked, “Have you ever smoked at least 100 cigarettes
in your entire life?” and “Do you now smoke cigarettes every day, some days, or not at all?"
Current smokers are defined as those who reported having smoked >100 cigarettes during their
lives and who currently smoked every day or some days (CDC, 2011). Because BRFSS data is
state-specific, median values rather than a national average are reported. Topics included in the
BRFSS questionnaire that has to do with demographic data include: age, sex, ethnicity, race,
marital status, education level, employment status, income, county of residence, pregnancy status
and children less than 18 years in household (CDC, 2011).
Response rate is an outcome rate with the number of complete and partial interviews in the
numerator and an estimate of the number of eligible units in the sample in the denominator. To
account for respondents accurately, the BRFSS uses the Council of American Survey Research
Organizations (CASRO) rates (CDC, 2011). Response Rate calculation assumes that the
unresolved numbers contain the same percentage of eligible households as the records whose
eligibility or ineligibility are determined. Therefore, the BRFSS uses proportions of unknown
households in each of the states to estimate the total number of households from those whose
eligibility is undetermined (CDC, 2011) In 2009, the median response rate was 52.48% (does
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not include Guam, Puerto Rico or the Virgin Islands) and in 2010 the median response rate was
54.60% (CDC, 2011).
To assess smoke-free policies, we used the American Lung Association State of Tobacco
Control 2008 report that follows state and federal policy advancements on important tobacco
control policies and allocates grades to tobacco control laws and regulation enacted as of January
1, 2009. The ALA State of Tobacco Control accounts for laws enacted by January of 2009, so
when individuals were surveyed in 2009 and 2010 and asked about their smoking status their
answers were dependent on the effects of existing laws, which was put into effect in the prior
year. The federal government along with all 50 states and the District of Columbia are evaluated
and graded to establish whether or not tobacco control laws are effective in protecting citizen’s
health against tobacco use and reducing the economic cost of tobacco on society (CDC, 2012).
The American Lung Association State of Tobacco Control report evaluates both state and federal
policies in four main areas: smoke-free air, tobacco prevention and control funding, cigarette
taxes and cessation coverage (Association, 2012). The calculation of state grades for tobacco
prevention and control spending is based on the Centers for Disease Control and Prevention’s
(CDC) published Best Practices for Comprehensive Tobacco Control Programs (Association,
2012). The smoke-free air laws grading is based on criteria developed by an advisory
committee convened by the National Cancer Institute with some modification to reflect the
current policy environment. The grading for state cigarette excise tax is based on the average of
all state taxes; the grades are adjusted annually to reflect the change in the average tax increase.
Finally, the state cessation coverage grading system is based on the U.S. Department of Health
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and Human Services’ published Clinical Practice Guideline on Treating Tobacco Use and
Dependence.
3.2 Study Measures
Consistent with previous CDC reports, two asthma prevalence questions are being used
by BRFSS as a measure of asthma data. First, an affirmative response to the question “Have you
ever been told by a doctor {nurse or other health professional} that you have asthma?’ defines a
status of lifetime asthma (CDC, 2011). Second, current asthma is defined as an affirmative
response to the previous question followed by an affirmative response to the following question,
“So you still have asthma?” Responses to these two questions are tabulated for adults for various
demographic groups.
To provide more meaningful results that are specific to unique groups, the analyses were
stratified related to current health conditions (asthma) and risk factors according to the following
characteristics: gender, age group, race, education, income and smoking status. We categorized
gender is to two groups (male/female); age in to four groups (18-34/35-44/45-64/65+); race in to
six groups (White/Black/American Indian/Alaskan Native/Hispanic/Other race); education into
three groups (high school education or less/some college/college 4 years or more); income into
five groups (<15000/15000-24999/25000-49999/50000-74999/ 7500); and smoking into three
groups (current smoker/former smoker/ non-smoker) (Table 1). These categories were chosen
because of the assurance of a reasonable sample size in each category. The data were analyzed
specifically for adults with asthma and adults without asthma.
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The American Lung Association State of Tobacco Control report evaluates both state and
federal policies by comparing them against targets based on the most current, recognized criteria
for effective tobacco control measures, and translating each state’s relative progress into a letter
grade of A through F (CDC, 2012). A grade of “A” is assigned for excellent tobacco control
policies while an “F” indicates inadequate policies. The American Lung Association (ALA)
tracks four components to grade states:
1. Tobacco Prevention and Control Spending
2. Smokefree Air
3. Cigarette Excise Tax
4. Cessation Coverage
For this study we used three of the four components because ‘Tobacco Prevention and Control
Spending’ did not change much among states. To examine the association between state of
tobacco control efforts and smoking rate among those with asthma, we summed for each of the
three components for each state to obtain overall policy grade for each state as shown in Table 5.
The overall policy grade was used because it accounts for the cumulative effects of all three
important laws selected:
1. Smoke-free air for its effects on reducing secondhand smoke in homes, work or
restaurants,
2. Increased cigarette excise tax for discouraging people who smoke as well as reducing
exposure to secondhand smoke.
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3. Smoking cessation programs for encourage people who smoke to quite will improve
smokers’ health and also will reduce exposure to secondhand smoke. As evident in
literature, the adverse health outcomes of smoking such as worsening asthma symptoms,
emphysema, chronic bronchitis, and risk of cancer can be substantially reduced the
sooner individuals quit smoking.
3.3 Analysis
The BRFSS dataset was obtained electronically and downloaded into SAS-callable
SUDAAN (version 10.0.0, RTI International, NC) for analysis. Alpha levels of <0.05 was used
for all statistical significance testing. Multivariate analyses were performed to reveal descriptive
statics regarding the study population. These analyses categorized and identified frequencies and
central tendencies around age distribution, race/ethnicity, education level of respondents, income
as well as smoking status (Table 2).
Multivariate logistic regression (dependent variable is Asthma- Yes/No) analysis was
also used to examine the association between demographic characteristics (age, sex, race,
ethnicity, education, income), smoking status, and asthma status (Table 2). We performed a
similar analysis to examine the association between smoking status and selected survey
respondents characteristics by asthma status and presented the results in Table 3. Percentage of
smokers among adults with and without asthma was estimated for each state by, adjusting for
sex, age, and race and results are presented in Table 4.
We tested for and found no multicollinearity among independent variables. For instance,
the two independent variables, education and income, did not have a high correlation. P-value of
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0.05 or less and not overlapping confidence interval (Gelman, 2000) are considered to be
statistically significant.
For the purposes of this analysis, demographic variables were re-coded in a variety of
ways that differed from the original coding of the data. The recoding structure is illustrated in
Table 1. Specifically, age, race, education level, household income, and smoking status were recoded to form more condensed and representative groups found within the study population.
Table 1 Initial and Re-coded Demographic Information
Characteristics

Initial Coding

Re-coded

Age

18-34- 18-24
25-34- 25-34
35-44- 35-44
45-54- 45-54
54-64- 54-64
64-99- 64 or older
BLANK- Not asked or missing

12345-

18-34
35-44
45-54
55-64
65+

Race

1234-

123456-

White
Black
AI/AN
Asian/Pacific Islander
Hispanic
Other

Hispanic/Latino

1- Yes
2- No
7- Don’t know/Not sure
9- Refused

White
Black or African American
Asian
Native Hawaiian or Other Pacific
Islander
5- American Indian, Alaska Native
6- Other
7- Don’t know/Not sure
8- Multiracial but preferred race not
asked
9- Refused
BLANK-Not asked or missing
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Education level

1- Never attended school or only
kindergarten
2- Grades 1 through 8 (Elementary)
3- Grades 9 through 11(Some high
school)
4- Grades 12 or GED (High school
graduate
5- College 1 year to 3 years (Some
college or technical school)
6- College 4 years or more (College
graduate)
9- Refused
BLANK- Not asked or Missing

1- High School (HS)
graduate or less
2- Some college
3- College 4 years or
more

Household
income

1- Less than $10,000
2- Less than $15,000 ($10,000 to less
than $15,000)
3- Less than $20,000 ($15,000 to less
than $20,000)
4- Less than $25,000 ($20,000 to less
than $25,000)
5- Less than $35,000($25,000 to less
than $35,000)
6- Less than $50,000($35,000 to less
than $50,000)
7- Less than $75,000 ($50,000 to less
than $75,000)
8- $75,000 or more
77- Don’t know/Not sure

12345-

<15,000
15,000-24,999
25,000-49,999
50,000-74,999
≥75,000

99- Refused
BLANK- Not asked or Missing
Smoking status

Asthma status

1- Current smoker- now smokes
every day
2- Current smoker- now smokes
some days
3- Former smoker
4- Never smoked
9- Don’t know/ Refused/ Missing
Lifetime Asthma:

1- Current smoker
2- Former smoker
3- Non-smoker

Combined:
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1- No
2- Yes
9- Don’t know/Refused/ Missing
Current Asthma:
1- No
2- Yes
9-Don’t know/Refused/ Missing

1- No
2- Yes
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CHAPTER IV
RESULTS

Results from the BRFSS dataset and ALA analysis are explained below. The results presented
address the three research questions posed at the onset of the study and outlined in chapter one of
this paper.

4.1 Characteristics of survey respondents
After recoding the demographic variables from initial categories, frequency statistics were run on
the following demographic markers: gender, age, race, highest level of education and income and
on smoking status. Table 2 presents the overall demographic characteristics of the survey
participants, as well as the current asthma prevalence by demographic and socioeconomic
variables. For the period 2009-2010, a total of 869,519 respondents from 50 states and the
District of Columbia (DC) were included in the analyses. Of those, 51% were female, mostly
white (69%), 35% had an education level that was equivalent to a 4 year college or more, and
nearly 18% were smokers.
4.2 Asthma prevalence and factors associated with asthma
Consistent with the previous CDC reports, our findings indicate that asthma status is
significantly associated with all selected demographic and socioeconomic characteristics of the
survey respondents (Table 2). The p-values for the chi-square test for independence to determine
whether there is a significant relationship between two categorical variables was less than 0.0001
in all the categories analyzed. Results of frequency statistics are further depicted in Table 2.
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Average annual current asthma prevalence was 8.5%. Consistent with the previous CDC reports,
asthma prevalence rate was higher in females than males (10.5% compared with 6.4%). The
current asthma prevalence for each age group were significantly higher than the reference age
group (aged 65+ years), however the highest was among adults aged 18-34 (9.3%; adjusted
prevalence rate ratio [aPR]=1.4) (Table 2). Among race/ethnic groups, current asthma
prevalence was high among other races (13.5%), followed by American Indian/ Alaskan Native
(13.0%), Black (10.0%), White (8.6%), Hispanic (6.7%), and finally Asian (4.8%). Also,
persons with some college degree (9.3%; [aPR]=1.1) and those in the lowest income bracket
(13.3%; [aPR]=1.9) had the highest current asthma prevalence in their respective categories.
Smoking status is significantly associated with current asthma status. Asthma prevalence was
higher among both current (10.5%; [aPR]=1.2) and former smokers (8.8%; [aPR]=1.2) compared
with non-smokers (7.8%; [aPR]=1.0).
Table 2 Characteristics of adult survey respondents— 2009–2010 Behavioral Risk Factor
Surveillance System data

Total

Total

Characteristics of
Survey
Respondents

Current Asthma
Prevalence1

Prevalence Rate
Ratio

Sample size2

% (95% CI)

% (95% CI)

aPR (95% CI)3

869519

100 (0–0)

8.5 (8.4–8.6)
p<0.00014

Sex
Male

329080

48.7 (48.5–48.9)

6.4 (6.3–6.6)

1.0 (reference)

Female

540439

51.3 (51.1–51.5)

10.5 (10.3–10.7)

1.6 (1.6–1.7)

Age, year range

p<0.0001

32

18–34

95841

28.2 (28.0–28.5)

9.3 (9.0––9.6)

1.4 (1.3–1.4)

35–44

116615

20.2 (20.1–20.4)

7.8 (7.6–8.1)

1.2 (1.2–1.3)

45–54

170300

19.5 (19.3–19.6)

8.4 (8.2–8.7)

1.3 (1.2–1.3)

55–64

194791

14.7 (14.6–14.8)

9.0 (8.8–9.2)

1.3 (1.2–1.3)

65+

284209

17.4 (17.2–17.5)

7.8 (7.6–7.9)

1.0 (reference)

p<0.0001

Race(nonHispanic)/
Ethnicity
White

690022

69.2 (69.0–69.4)

8.6 (8.5–8.8)

1.0 (reference)

Black

68024

10.2 (10.0–10.3)

10.0 (9.6–10.5)

1.0 (1.0–1.1)

AI/AN5

11961

1.1 (1.0–1.1)

13.0 (11.7–14.5)

1.3 (1.2–1.5)

15899

3.8 (3.7–3.9)

4.8 (4.2–5.5)

0.6 (0.5–0.7)

Hispanic

53732

13.6 (13.4–13.8)

6.7 (6.3–7.1)

0.7 (0.6–0.7)

Other race

18973

2.2 (2.1–2.3)

13.5 (12.5–14.5)

1.4 (1.3–1.6)

Asian/Pacific
Islander

p<0.0001

Education level
High School
(HS) graduate
or less

340602

38.4 (38.2–38.6)

9.1 (8.9–9.3)

1.0 (1.0–1.1)

Some college

232036

26.3 (26.1–26.5)

9.3 (9.1–9.6)

1.1 (1.1–1.1)

College 4
years or more

293834

35.3 (35.1–35.5)

7.3 (7.1–7.5)

1.0 (reference)

Household
Income

p<0.0001
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86389

10.4 (10.2–10.5)

13.3 (12.8–13.8)

1.9 (1.8–2.0)

$15000–
$24999

133940

15.8 (15.6–16.0)

10.3 (9.9–10.6)

1.5 (1.4–1.6)

$25,000–
$49999

205802

24.6 (24.4–24.8)

8.1 (7.9–8.4)

1.2 (1.1–1.2)

$50000–
$74999

120544

16.0 (15.9–16.2)

7.7 (7.4–8.0)

1.1 (1.0–1.2)

≥$75000

202340

33.2 (32.9–33.4)

6.8 (6.6–7.0)

1.0 (reference)

<$15000

p<0.0001

Smoking status
Current
smoker

139086

17.6 (17.4–17.8)

10.5 (10.2–10.9)

1.2 (1.2–1.3)

Former
smoker

263614

24.9 (24.7–25.1)

8.8 (8.6–9.0)

1.2 (1.2–1.2)

461190

57.5 (57.3–57.7)

7.8 (7.7–8.0)

1.0 (reference)

Non-smoker
1

Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health
professional that you had asthma?” and “Do you still have asthma?”
2
Sample size (unweighted) for the corresponding subpopulations
3
Prevalence rate ratio (95% confidence interval) adjusted for age, sex, race, ethnicity, education, income, smoking.
4
P-values for the chi-square test for independence to determine whether there is a significant relationship between
two categorical variables.
5
American Indian/ Alaskan Native

4.3 Smoking rate by selected characteristics among adults with and without asthma
Following the establishment of baseline demographic characteristics of BRFSS
respondents and asthma status among them, we further examined smoking rate among those with
and without asthma and identify the factors associated with high smoking rate (Table 3). Cross
comparison between adults with asthma and adults without asthma, smoking rate was higher
among those with asthma (21.7%) than those without asthma (17.2%). Comparison between the
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different sub-group within adults with asthma and adults without asthma indicate that same
demographic characteristics have the high smoking rate. Regardless of asthma status, smoking
rates are higher among males than females, ages 18-34, 35-44, 45-54, 55-64 than ages 65+;
American Indian/Alaska Native (AI/AN) and other race than whites; adults with high school or
less education and adults with some college education than adults with 4 years or more college
education, and among all adults with income of less than $75,000 than adults with higher income
(>=$75,000) (Table 3). Worth noting that, smoking rates are lower among blacks, Asian/Pacific
Islander, and Hispanic for both adults with asthma and without asthma, compared with whites.
For example, percentage of smoking was 23.4% for adult males with asthma and 19.3% for adult
males without asthma. Both rate for males were higher than rates for females (20.7% vs. 15.1%)
(Table 3).
Table 3 Percentage of smokers by asthma1 status and selected demographic characteristics—
2009–2010 Behavioral Risk Factor Surveillance System data
Adults with asthma
(n=78,159)
Percentage of smokers (n=15,597)
% (95% CI)
Total

aPR (95% CI)2

21.7 (21.1-22.4)

Adults without asthma
(n=783,417)
Percentage of smokers
(n=123,090)
% (95% CI)
aPR (95% CI)
17.2 (17.0-17.4)

Sex
Male

23.4 (22.2-24.7)

1.0 (reference)

19.3 (19.0-19.6)

1.0 (reference)

Female

20.7 (20.0-21.4)

0.9 (0.8-0.9)

15.1 (14.9-15.3)

0.8 (0.8-0.8)

Age, year range
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18–34

26.1 (24.5-27.7)

3.0 (2.8-3.3)

21.5 (21.1-22.0)

3.1 (3.0-3.2)

35–44

22.9 (21.5-24.4)

3.2 (2.9-3.5)

17.7 (17.3-18.1)

3.0 (2.9-3.2)

45–54

25.1 (23.9-26.3)

3.2 (2.9-3.4)

19.6 (19.2-19.9)

3.1 (3.0-3.2)

55–64

19.6 (18.6-20.7)

2.4 (2.2-2.6)

16.2 (15.9-16.5)

2.5 (2.4-2.5)

65+

9.9 (9.3-10.6)

1.0 (reference)

8.2 (8.0-8.4)

1.0 (reference)

White

21.4 (20.7-22.1)

1.0 (reference)

17.5 (17.3-17.7)

1.0 (reference)

Black

22.9 (20.9-25.0)

0.8 (0.7-0.9)

19.2 (18.6-19.9)

0.8 (0.8-0.9)

AI/AN3

40.4 (34.7-46.4)

1.4 (1.2-1.6)

31.9 (29.7-34.2)

1.3 (1.2-1.4)

9.7 (6.2-14.8)

0.6 (0.4-0.9)

9.4 (8.3-10.6)

0.6 (0.5-0.7)

Hispanic

19.2 (17.0-21.7)

0.6 (0.5-0.7)

14.4 (13.7-15.1)

0.5 (0.5-0.5)

Other race

31.1 (27.5-34.9)

1.1 (1.0-1.3)

24.8 (23.3-26.4)

1.2 (1.1-1.2)

Race(non-Hispanic)/
Ethnicity

Asian/Pacific
Islander

Education level
High School (HS)
graduate or less

2.5 (2.4-2.5)
31.3 (30.1-32.4)

2.6 (2.3-2.8)

24.4 (24.1-24.8)

22.2 (21.0-23.4)

2.0 (1.8-2.2)

19.1 (18.7-19.5)

2.0 (1.9-2.0)

8.3 (7.6-9.0)

1.0 (reference)

8.2 (8.0-8.5)

1.0 (reference)

<$15000

36.7 (34.8-38.7)

3.1 (2.8-3.5)

27.2 (26.4-27.9)

2.3 (2.2-2.4)

$15000–$24999

31.8 (30.1-33.6)

2.9 (2.5-3.2)

25.4 (24.8-26.0)

2.2 (2.1-2.2)

Some college
College 4 years or
more
Household Income
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$25,000–$49999

22.6 (21.2-24.1)

2.2 (1.9-2.5)

20.0 (19.6-20.5)

1.7 (1.6-1.8)

$50000–$74999

14.7 (13.3-16.1)

1.5 (1.3-1.7)

15.3 (14.8-15.7)

1.3 (1.3-1.4)

≥$75000

8.4 (7.6-9.3)

1.0 (reference)

10.3 (10.0-10.5)

1.0 (reference)

1

Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health
professional that you had asthma?” and “Do you still have asthma?”
2
Prevalence rate ratio (95% confidence interval) adjusted for age, sex, race, ethnicity, education, income, smoking.
3
American Indian/ Alaskan Native

4.4 Adjusted smoking rate by asthma status for each state
After assessing the asthma and smoking status by demographic and socioeconomic
variables, the percentage of smokers among adults by asthma status and state was examined. A
sample size of 869,519 respondents was collected and the percent smokers for each state was
estimated by adjusting for sex, age and race. Overall, the analysis of all 50 states shows that the
percentage of adult smokers who have asthma is significantly higher than the percentage of adult
smokers without asthma. The U.S. total includes all 50 states plus DC and excludes the three
territories (Guam, Virgin Island, and Puerto Rico). Of all the states, 24 were found to have
higher rates of adults with asthma who smoke than adults without asthma who smoke. The states
that were found to have higher rates of smoking adults with asthma are indicated with an asterisk
in the ‘Adults with asthma who smoke’ percentage column (Table 4). Among states, the lowest
percentage of smokers among adults with asthma was in Utah at 11.2% . Of the 50 states,
Alabama, Arkansas, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, Mississippi, South
Carolina, Tennessee, and West Virginia had the highest smoking rate as seen in Map as top 20%.
Arkansas (+9.1%), Kentucky (+9.6%), Mississippi (+7.6%), South Carolina (+8.3%), and
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Tennessee (+9.0%) had the largest positive percentage difference between adults with asthma
who smoke and adults without asthma who smoke (Table 4).
Table 4 Percentage of smokers among adults by asthma1 status and states— 2009–2010
Behavioral Risk Factor Surveillance System data
Total
Sample %3
size2
U.S.
Total4

(95% CI))3

869519

Adults with asthma
who smokes
(n=15,597)
%3
(95% CI))3

Adults without
asthma who smokes
(n=123,090)
%3
(95% CI))3

*21.4

(20.8-22.1)

17.3

(17.1-17.5)

AL

14457 22.1

(21.0-23.2)

26.2

(22.6-30.1)

22.0

(20.9-23.2)

AK

4396 17.2

(15.5-19.0)

23.4

(16.7-31.8)

20.1

(18.2-22.2)

AZ

11231 15.7

(14.4-17.1)

16.3

(12.5-20.9)

15.6

(14.2-17.1)

AR

8036 21.8

(20.3-23.4)

*30.6

(25.1-36.8)

21.5

(20.0-23.2)

CA

35170 13.3

(12.7-13.9)

*16.2

(14.2-18.4)

12.2

(11.6-12.7)

CO

23619 16.2

(15.4-17.0)

15.4

(12.8-18.4)

16.6

(15.8-17.5)

CT

13272 14.5

(13.5-15.5)

16.1

(12.8-20.1)

14.2

(13.2-15.4)

DE

8607 17.7

(16.5-19.0)

*23.2

(18.8-28.2)

17.3

(16.0-18.7)

DC

7880 14.9

(13.8-16.1)

15.2

(12.1-18.9)

15.6

(14.4-16.9)

FL

47164 18.1

(17.3-19.0)

19.6

(16.8-22.8)

17.0

(16.1-17.9)

GA

11684 17.0

(16.0-18.2)

21.2

(17.0-26.1)

17.5

(16.3-18.7)

HI

13235 16.5

(15.4-17.8)

16.6

(13.8-19.8)

14.8

(13.8-15.8)

ID

12399 15.5

(14.5-16.5)

17.8

(14.7-21.4)

15.9

(14.9-17.0)
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IL

11047 17.8

(16.7-18.9)

18.5

(14.9-22.6)

17.6

(16.5-18.8)

IN

19507 21.6

(20.7-22.6)

*26.9

(23.9-30.2)

21.8

(20.8-22.8)

IA

12126 16.5

(15.5-17.5)

*22.4

(18.8-26.4)

16.2

(15.2-17.2)

KS

27482 17.0

(16.3-17.7)

*21.5

(18.8-24.4)

17.0

(16.3-17.8)

KY

17713 24.6

(23.4-25.8)

*34.0

(30.2-38.2)

24.4

(23.1-25.7)

LA

15914 21.1

(20.1-22.1)

25.8

(21.5-30.7)

21.8

(20.8-22.8)

ME

16214 17.7

(16.8-18.6)

20.8

(18.1-23.6)

17.5

(16.6-18.4)

MD

17776 15.1

(14.2-16.0)

*20.1

(16.7-24.0)

14.9

(14.0-15.8)

MA

33042 14.7

(14.0-15.3)

*18.9

(16.8-21.2)

14.0

(13.3-14.7)

MI

18118 18.8

(18.0-19.7)

21.0

(18.3-24.0)

19.1

(18.2-20.1)

MN

14579 15.3

(14.4-16.4)

16.1

(12.6-20.4)

15.8

(14.8-16.9)

MS

19283 22.3

(21.3-23.3)

*30.3

(26.8-34.0)

22.7

(21.7-23.8)

MO

10486 21.4

(20.2-22.8)

25.2

(20.6-30.5)

21.8

(20.5-23.2)

MT

14922 16.9

(15.9-18.0)

*24.1

(20.2-28.5)

17.3

(16.2-18.5)

NE

32377 16.6

(15.6-17.6)

17.5

(14.2-21.3)

17.0

(16.0-18.1)

NV

7753 21.4

(19.8-23.2)

23.0

(18.0-28.8)

21.6

(19.8-23.4)

NH

12035 15.9

(14.9-16.9)

17.3

(14.6-20.5)

16.1

(15.0-17.2)

NJ

24828 15.7

(15.0-16.5)

16.0

(13.7-18.5)

15.1

(14.3-15.9)

NM

15834 18.2

(17.2-19.4)

20.9

(17.3-25.1)

18.0

(16.9-19.1)

NY

15877 17.3

(16.5-18.3)

*21.6

(18.7-24.8)

16.4

(15.4-17.3)

NC

25416 19.5

(18.6-20.4)

23.5

(20.5-26.9)

19.8

(18.9-20.8)

ND

9530 16.9

(15.8-18.0)

20.6

(16.8-25.0)

17.7

(16.5-19.0)
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OH

19631 21.0

(20.1-21.9)

*26.5

(23.2-30.0)

20.9

(20.0-21.9)

OK

15590 22.7

(21.7-23.6)

*29.9

(26.7-33.4)

24.0

(23.0-25.0)

OR

9360 15.7

(14.6-17.0)

*23.4

(19.2-28.1)

15.8

(14.6-17.1)

PA

20415 19.6

(18.7-20.4)

*24.2

(21.4-27.2)

18.8

(17.9-19.7)

RI

12895 15.3

(14.3-16.3)

16.0

(13.2-19.3)

15.4

(14.4-16.5)

SC

19293 20.0

(18.9-21.2)

*28.4

(23.5-34.0)

20.1

(18.9-21.3)

SD

13552 15.4

(14.4-16.4)

17.6

(14.4-21.2)

16.4

(15.3-17.5)

TN

11346 20.8

(19.6-22.1)

*29.5

(24.6-35.0)

20.5

(19.2-21.8)

TX

29685 17.4

(16.5-18.4)

*22.2

(19.0-25.8)

16.6

(15.7-17.6)

UT

20334 08.8

(08.2-09.4)

11.2

(9.2-13.6)

9.3

(8.7-10.0)

VT

13462 15.9

(15.0-16.8)

*21.3

(18.3-24.7)

15.6

(14.7-16.6)

VA

10576 18.5

(16.9-20.2)

24.2

(19.7-29.5)

18.4

(16.7-20.2)

WA

39922 14.7

(14.1-15.2)

*18.6

(16.6-20.7)

14.7

(14.1-15.3)

WV

9218 26.1

(24.9-27.3)

*32.8

(28.5-37.4)

25.6

(24.3-26.9)

WI

9334 18.3

(17.0-19.8)

*25.0

(20.1-30.6)

18.3

(16.9-19.9)

WY

11897 18.9

(17.9-20.0)

21.1

(17.7-25.0)

19.7

(18.5-20.8)

*

Percentage of smokers among adults with asthma was greater than the percentage of smokers among adults who
does not have asthma
1
Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health
professional that you had asthma?” and “Do you still have asthma?”
2
Sample size (unweighted) for the corresponding subpopulations
3
Adjusted for sex, age, and race/ethnicity
4
U.S. Total includes 50 states plus DC and excludes the three territories

40

Map1. Percentage of smokers among adults with asthma by state

4.5 Adjusted smoking rate among adults with asthma and level of tobacco control by states
After examining the percentage of smokers among adults by asthma status and state, the
smoking rate among adults with asthma as it relates to different measure of tobacco control was
analyzed by state. Data from the ALA 2008 report that tracks progress on key tobacco control
policies at the state level were used to create Table 5. In Table 5, for each state, we presented
adjusted (by age, sex, and race) smoking prevalence rate among adults with asthma and data
from the ALA 2008 report on the three policies- smoke-free air (total score, grade), cigarette
excise tax (tax rate per pack of 20 cigarettes, grade), and cessation coverage (total score, grade).
We calculated, the ‘Overall Policy Grade’ column, which is the cumulative grade of all policies
implemented by using the scores for grades as A=4, B=3, C=2, D=1, F=0. Tables 6 and 7 take a

41

closer look at the states with the highest and lowest smoking rates for adults with asthma and
overall smoke-free policy grade as indication of state of tobacco control efforts to examine the
association between them.
Table 5 Percentage of adults with asthma who smoke and level of tobacco control by state.
Level of tobacco control
Smokefree Air
Cigarette Excise
1
Grading
Tax overview1

Cessation Coverage
Grading1

Overall
Policy
Grade

State

% Adults
with
asthma
who
smoke2

Total
Score

Grade

Tax Rate Grade
(per
pk.of 20)

Total
Score

Grade

AL

26.2

20

F

$0.425

F

17

F

0

AK

23.4

21

F

$2.00

B

19

F

3

AZ

16.3

46

A

$2.00

B

26

D

8

AR*

30.6

36

B

$0.59

F

28

D

4

CA

16.2

40

A

$0.87

D

28

D

6

CO

15.4

40

A

$0.84

D

21

F

5

CT

16.1

39

C

$2.00

B

5

F

5

DE*

23.2

46

A

$1.15

D

15

F

5

DC

15.2

36

A

$2.00

B

28

D

8

FL

19.6

41

B

$0.339

F

21

F

3

GA

21.2

31

C

$0.37

F

3

F

2

HI

16.6

43

A

$2.00

B

21

F

7

42

ID

17.8

36

B

$0.57

F

21

F

3

IL

18.5

48

A

$0.98

D

29

C

7

IN*

26.9

7

F

$0.995

D

30

C

3

IA*

22.4

42

A

$1.36

C

18

F

6

KS*

21.5

16

F

$0.79

D

18

F

1

KY*

34

3

F

$0.30

F

18

F

0

LA

25.8

36

B

$0.36

F

16

F

3

ME

20.8

42

A

2.00

B

29

C

9

MD*

20.1

42

A

$2.00

B

14

F

7

MA*

18.9

42

A

$2.51

A

29

C

10

MI

21

17

F

$2.00

B

21

F

3

MN

16.1

41

A

$1.504

C

35

B

9

MS*

30.3

11

F

$0.18

F

25

D

1

MO

25.2

16

F

$0.17

F

4

F

0

MT*

24.1

35

I3

$1.70

C

18

F

2

NE

17.5

18

I4

$0.64

D

30

C

3

NV

23

37

B

$0.80

D

32

C

6

NH

17.3

33

D

$1.33

C

22

F

3

NJ

16

41

A

$2.575

A

24

F

8

NM

20.9

40

A

$0.91

D

33

B

8

NY*

21.6

43

A

$2.75

A

24

F

8

NC

23.5

6

F

$0.35

F

24

F

0

43

ND

20.6

32

C

$0.44

F

33

B

5

OH*

26.5

44

A

$1.25

C

23

F

6

OK*

29.9

34

D

$1.03

D

24

F

2

OR*

23.4

45

A

$1.18

D

34

B

8

PA*

24.2

36

C

$1.35

C

32

C

6

RI

16

41

A

$2.46

A

36

B

11

SC*

28.4

10

F

$0.07

F

19

F

0

SD

17.6

30

F

$1.53

C

15

F

2

TN*

29.5

34

C

$0.62

D

6

F

3

TX*

22.2

9

F

$1.41

C

18

F

2

UT

11.2

41

A

$0.695

D

21

F

5

VT*

21.3

36

A

$1.99

B

22

F

7

VA

24.2

13

F

$0.30

F

23

F

0

WA*

18.6

47

A

$2.025

B

24

F

7

WV*

32.8

7

F

$0.55

F

21

F

0

WI*

25

16

F

$1.77

C

33

B

5

WY

21.1

0

F

$0.60

D

19

F

1

*

Percentage of smokers among adults with asthma was greater than the percentage of smokers among adults who
does not have asthma
1
SOURCE: American Lung Association. State of Tobacco Control 2008 http://www.lung.org/aboutus/publications/index.html#presidents-report
2
Adjusted for sex, age, and race/ethnicity
3
Montana gets an “I” for Incomplete because they passed a smokefree law in 2005, but parts of it were delayed from
taking effect until October 1, 2009.
4
Nebraska gets an “I” for Incomplete because they passed a smokefree law in 2008, but it does not take effect until
June 1, 2009.
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4.5 Evaluating the association between the level of tobacco control and smoking rate among
adults with asthma by states
We examined the association between the smoking rate among adults with asthma and
measure of state of tobacco control efforts among states. Smoking rates for states were divided
into five quintiles and overall policy grade, mean, minimum, and maximum values of overall
tobacco control policy grade for states in each 5 quintile were calculated (Table 6). To show the
impact that tobacco control had on smoking rate, we performed t-test to examine if mean tobacco
control policy grades for states in quintile 1(Q1) to Q4 were significantly different than the mean
tobacco control policy grade for states with the highest smoking rate (Q5=highest 20%). The
mean tobacco control policy grade was calculated based on the three tobacco control laws. We
assigned a grade point by giving 4 points for grade A, 3 points for B, 2 points for C, 1 point for
D, and 0 points for F. Then the points for the 3 components were summed to derive the total
points (overall policy grade) for each state. The total points ranges from zero to 12. The higher
the overall policy grade, the better the tobacco control effort in the state. The mean tobacco
control policy grade for states in Q1, Q2, and Q3 groups were significantly higher than the grade
for states in Q5 with a p-value less than 0.05.
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Table 6 Percentiles of smoking rate (adjusted for sex, age, and race) among adults with asthma
and corresponding grades for tobacco control status
Quintiles of smoking rate among adults with asthma (20% of states in
each quintile based on smoker percentages)
Smoking Rate

Q1 (lowest = Q2 (second = Q3 (middle =
11.2%17.0%20.8%16.7%)
20.7%)
22.9%)

Q4 (fourth =
23.0%25.7%)

Q5 (highest
= 25.8%34.0%)

72

50

47

35

22

Range (min-max
grade)

5-11

2-10

1-9

0-8

0-6

Mean grade (std
dev)

7.2 (1.99)

5.0 (2.62)

4.7 (3.20)

3.5 (2.92)

2.0 (2.00)

T-test

Q1 vs. Q5

Q2 vs. Q5

Q3 vs. Q5

Q4 vs. Q5

0.0000*

0.0096*

0.0369*

0.1925

Overall Policy
Grade

P-value

*Mean grades for the two groups are significantly different (t-test: p-value <0.05)

In addition to measuring the effects of tobacco control measures nationwide, the states
with the lowest and highest smoking rates among adults with asthma were identified and listed in
Table 7. Table 7 shows that none of the states in the lowest quintile have an asterisk next to their
name, indicating that the percentage of adult smokers with asthma is not greater than the
percentage of adult smokers who do not have asthma. On the other hand, nine out of the eleven
states listed in the highest quintile column have an asterisk next to their name. The states in the
lowest quintile (5-11) had an overall policy grade range that was significantly higher than the
states in the highest quintile (0-4) (t-test: p-value <0.00001). Also, the ranges of smoking rates
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in the lowest (11.2-16.6) and highest quintiles (25.8-34.0) were found to be statistically
significant.
Table 7 Evaluating the tobacco control status of states with the lowest and highest smoking rates
(adjusted for sex, age, and race) among adults with asthma
Note: none of the lowest states have asterisk next to the name.
The states with the lowest smoking rates
among adults with asthma (below 20th
percentile of 17.0%)
State

% Smokers

The states with the highest smoking rates
among adults with asthma (80th percentile
of 25.8% and above)

Overall
Policy Grade

State

% Smokers

Overall
Policy Grade

UT

11.2

5 LA

25.8

3

DC

15.2

8 AL

26.2

0

CO

15.4

5 OH*

26.5

6

NJ

16.0

8 IN*

26.9

3

RI

16.0

11 SC*

28.4

0

CT

16.1

5 TN*

29.5

3

MN

16.1

9 OK*

29.9

2

CA

16.2

6 MS*

30.3

1

AZ

16.3

8 AR*

30.6

4

HI

16.6

7 WV*

32.8

0

KY*

34.0

0

Total grade

72

22

47

7.2 (1.99)

Mean (std
dev)*
Range

(11.2-16.6)

(5-11)

2.0 (2.0)

(25.8-34.0)

*Mean grades for the two groups are significantly different (t-test: p-value <0.00001)

(0-4)
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CHAPTER V
DISCUSSION AND CONCLUSION
5.1 Discussion
The first effort to educate the public on the harmful effects of second hand smoking was in
1971 when Surgeon General Jesse Steinfeld suggested that low-dose exposure to cigarette smoke
may have a potential public health risk for nonsmokers (Institute, 2000). Fifteen years later, in
1986, Surgeon General Dr. Koop released a report The Health Consequences of Involuntary
Smoking. The report included the following:
“Involuntary smoking is a cause of disease, including lung cancer, in health nonsmokers.
The children of parents who smoke compared with the children of nonsmoking parents
have an increased frequency of respiratory infections, increased respiratory symptoms,
and slightly smaller rates of increase in lung function as the lung matures.
The simple separation of smokers and nonsmokers within the same air space may reduce,
but does not eliminate, the exposure of nonsmokers to environmental tobacco
smoke.”(Institute, 2000)
After the publication of Dr. Koop’s report, federal agencies started taking steps to
educate the public on the dangers of tobacco smoke to smokers as well as non-smokers. One of
the most significant steps taken by a federal agency came in 1990 when the U.S. Environmental
Protection Agency (EPA) released a publication Assessment on Environmental Tobacco Smoke
(ETS) in which they classify tobacco smoke as a Group A carcinogen that can cause lung cancer
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in nonsmokers (Institute, 2000). Since then, a multitude of reviews conducted by medical and
governmental organizations leave no doubt that environmental tobacco smoke causes disease in
smokers and non-smokers. The health effects associated with exposure to ETS include:
developmental (fetal growth and sudden infant death syndrome), respiratory (acute lower
respiratory tract infections in children, asthma induction and exacerbation in children, chronic
respiratory symptoms in children, eye and nasal irritation in adults, and middle ear infections in
children), carcinogenic effects (lung cancer and nasal sinus cancer), and cardiovascular effects
(heart disease mortality and acute and chronic coronary heart disease morbidity) (Institute,
2000).
Multiple factors play a role in the development of asthma and the exacerbation of asthma
symptoms. We examined the predictive ability of selected factors on asthma prevalence in the
2009 and 2010 BRFSS data. We found that all selected potential predictive factors were
significant predictors of current asthma for the overall study population. These findings are
consistent with those of previous research (Zahran, 2012;Strine, 2004;Gwynn, 2004).
Examining data from the ALA Tobacco Control Report of 2008 along with smoking rate in
states, our findings indicate that states with better tobacco control policies/laws had lower
smoking rate among adults with asthma than states that do not have.
In order to combat this public health concern, the public health community has been involved
in policies that have a more comprehensive approach designed to change environmental and
social norms. The findings of this paper show evidence of significant association between
smoking and asthma status and lower smoking prevalence rate among adults with asthma in
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states with three tobacco control interventions. This study was unusual in specifically linking
national reduced smoking prevalence among adults with asthma with an increasing tobacco
control measures (smoke-free environment, cigarette excise tax and cessation coverage) as
opposed to specific community based efforts (Dockery, 1993;Juster, 2007;Head, 2012;Roberts,
2012;Huang, 2012) and specific tobacco control policies (Juster, 2007;Roberts, 2012;Huang,
2012;Wakefield, 2008;Kabir, 2009;Jill S. Rumberger, 2010;Dilley, 2012). The study also
furnished great detail on the link between smoking prevalence and specifically asthma rates as it
relates to policy which is lacking in research, most literature reviewed discuss the link between
smoking prevalence and policy discounting the effect smoking has on asthma rates (Juster,
2007;Roberts, 2012;Head, 2012;Huang, 2012;Wakefield, 2008;Kabir, 2009;Jill S. Rumberger,
2010;Dilley, 2012). While there is a wealth of research on cessation outcomes related to specific
legislation measure, there is less research on population-level smoking prevalence.
Although, the association between lower smoking rate and the implementation of the tobacco
control policies and measures is based on state level evaluation (not based on individual data),
nonetheless the findings clearly indicate a strong association, which brings the importance of
government role in reducing smoking rate and related harmful health effects.
Policy measures
Among the three policy measures discussed in this study, Cigarette excise tax is the most
controversial. President Obama states that his proposal for a 94-cent federal tax increase ‘would
have substantial public health benefits, particularly for young America’ (Budget, 2013). This is
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following the 62 cent tax increase in 2009 which effectively dropped cigarette sales by an
estimated 10% (Huang, 2012). This topic is controversial for two reasons. First, sales taxes are
viewed as regressive because the higher income groups invest a smaller share of their income
than the poor. Second, since the prevalence of smoking is higher among the poor, cigarettes are
disproportionately consumed by the poor. While excise tax could have some sort of
discriminatory selection because it is targeting the people who cannot afford to buy cigarettes.
However, it is this sector of the community that is most affected by smoking rate and asthma
based on statistics (Table 2 and 3). Public health policy aims to treat behavioral change, the
extent to which higher taxes cause smokers to quit or cut back on smoking.
If the poor cut back enough relative to the rich, the smoking and asthma rates should be
balanced in a way that will promote the policy’s impact as possible effective preventive measure.
Some may argue that putting this additional burden on low income populations could also lead to
some other unfavorable results like cutting back from their expense on food and other essential
necessities and using the money to buy cigarettes which will create financial stress (Martire,
2011). However, if higher cigarette tax forces the poor in society to cut back on their
consumption of cigarettes that will meet the goal of reducing overall smoking rate, exposure to
second hand smoke as well as lessen the economic burden on the health care system brought on
by smoking related diseases.
It is important to note that, as demonstrated by Martire et al., the financial stress on
responses to price increases may lower the quit rates among certain smokers. Not all smokers
among the poor population will respond the same to the increase in cigarette tax, some may
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choose to quite in so doing they eliminate the financial burden of cigarette taxes. Others may
lessen their daily consumption and be left where they started spending the same amount yet
consuming less. The final group is that which will continue to smoke the same amount, spending
more than they did previously and experiencing additional financial stress. An approach that
may prove beneficial is to create policy that will support smokers that are struggling to quit by
providing them with free or subsidized smoking cessation resources that will reduce their
economic burdens. This approach has been implemented and appropriately funded in eight states
as of 2011; according to the CDC’s Best Practices for Comprehensive Tobacco Control
Programs the per capita recommended level of investment ranges from $9.23 to $18.02 based on
state’s specific characteristics. The report confirms that if states were to continue the level of
investment for a 5 year time span, there would see the number of smokers decline by 5 million.
An additional advantage to implementing and funding tobacco cessation programs is that
fewer young adults (particularly in the 8th through 12th grade range) would smoke. Tauras et al.,
published a study in the American Journal of Public Health in which they conclude that if states
invested the CDC-recommended minimum level for tobacco control, the estimates for youth
smoking prevalence would have been lowered by 3.5- 13.5% nationwide (Tauras, 2005).
5.2 Study Limitations
The use of BRFSS dataset is a great strength as it has been applied to research and evaluated
by the CDC and participating states since 1984 (Prevention, 2011). The content of the
surveillance system which includes: designs of the questionnaire, survey questions, interviewing
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methods, procedures for data collection and processing has been progressively developed over
the past 29 years to improve data quality. At large, statistics from the BRFSS is relied on and
accurate. However, there were several limitations in this study.
First, the BRFSS data is collected by telephone interviews. Individuals who live in
households without a residential telephone (1.7%) are not included (Prevention, 2011).
Therefore, the BRFSS might exclude persons of lower socioeconomic status or households with
cellular phones only (24.9%) (CDC, 2011). Second, the survey is based on populations that are
not institutionalized; thereby excluding persons residing elsewhere, such as nursing homes or
long-term care facilities, this may affect the findings for older adults. Third, the BRFSS data are
self-reported by respondents and smoking status was not validated by biochemical tests. As a
result, smoking maybe underreported because of social desirability bias. Fourth, the sampling
frame of the BRFSS is the entire state; therefore, some rural areas might be represented by
relatively few interviews. Finally, the study assumes that the full benefits of the tobacco control
measures will be accrued within a year of implementation. However, in reality, it may take years
before individuals decide to change their smoking habits and for society to start reaping the
economic and health benefits of lower smoking rates.
5.3 Conclusion
Our findings show that predictors of asthma differed by demographic characteristics. As in
the results for whites and blacks, all selected potential factors (sex, age, education, income, and
smoking status) were significant predictors of asthma prevalence in the overall adult population.
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Also, shown in this study is the link between smoking status and asthma status nationwide as it
affects different demographic groups in the population. Finally, we were able to show the link
between smoking rate and state of tobacco control efforts. The study findings indicate that
comprehensive policy measures have a significant impact on the smoking rate nationwide.
Although most U.S. state smoke-free policies and regulations are relatively new, it is evident that
that these laws are effective in promoting cessation among adults and reducing nonsmokers’
exposure to secondhand smoke. The study found that smoke-free laws will improve health by
lowering smoking rates among adult smoker that will in turn reduce harmful health effects due to
smoking and exposure to secondhand smoke, including exacerbation of asthma symptoms.
Further studies are warranted to track impact of interventions expected to affect smoking on
the general population. Observational studies with longitudinal design are needed to employ
clear definitions of policy components and careful control for confounding. These studies will
be important in developing targeted interventions to reduce the health and economic impact of
smoking among disproportionately affected segments of the United States population.
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